This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its chiral structure makes it valuable in the production of enantiomerically pure drugs, particularly those targeting central nervous system disorders. It is often employed in the development of selective serotonin reuptake inhibitors (SSRIs) and other neuroactive agents, where its specific stereochemistry enhances the efficacy and reduces side effects of the final drug product. Additionally, it finds application in research settings for studying receptor interactions and developing novel therapeutic compounds.